Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS)
CNY 17.42
(6.48%)
CNY 17.42
(6.48%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 192.99 Million CNY | 28.02% |
| 2022 | 150.75 Million CNY | 44.29% |
| 2021 | 104.47 Million CNY | 9.34% |
| 2020 | 95.55 Million CNY | 15.42% |
| 2019 | 82.78 Million CNY | 26.77% |
| 2018 | 65.3 Million CNY | 2.46% |
| 2017 | 63.73 Million CNY | -1.64% |
| 2016 | 64.79 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 63.02 Million CNY | -4.53% |
| 2024 Q2 | 66.01 Million CNY | 23.3% |
| 2024 Q1 | 53.54 Million CNY | 3.65% |
| 2023 Q3 | 50.23 Million CNY | 7.69% |
| 2023 Q1 | 44.44 Million CNY | 35.46% |
| 2023 FY | 192.99 Million CNY | 28.02% |
| 2023 Q2 | 46.65 Million CNY | 4.96% |
| 2023 Q4 | 51.65 Million CNY | 2.82% |
| 2022 Q3 | 39.53 Million CNY | 4.81% |
| 2022 FY | 150.75 Million CNY | 44.29% |
| 2022 Q4 | 32.81 Million CNY | -17.01% |
| 2022 Q2 | 37.72 Million CNY | -7.38% |
| 2022 Q1 | 40.72 Million CNY | 38.36% |
| 2021 Q4 | 29.43 Million CNY | 26.56% |
| 2021 Q3 | 23.26 Million CNY | -32.24% |
| 2021 Q1 | 17.45 Million CNY | -26.09% |
| 2021 Q2 | 34.32 Million CNY | 96.7% |
| 2021 FY | 104.47 Million CNY | 9.34% |
| 2020 Q2 | 35.78 Million CNY | 141.19% |
| 2020 FY | 95.55 Million CNY | 15.42% |
| 2020 Q4 | 23.61 Million CNY | 10.81% |
| 2020 Q3 | 21.31 Million CNY | -40.46% |
| 2020 Q1 | 14.83 Million CNY | -28.86% |
| 2019 Q3 | 20.85 Million CNY | 1.57% |
| 2019 FY | 82.78 Million CNY | 26.77% |
| 2019 Q4 | 20.85 Million CNY | 0.0% |
| 2019 Q2 | 20.53 Million CNY | 0.0% |
| 2019 Q1 | 20.53 Million CNY | 0.0% |
| 2018 FY | 65.3 Million CNY | 2.46% |
| 2017 FY | 63.73 Million CNY | -1.64% |
| 2016 FY | 64.79 Million CNY | 0.0% |